-
1
-
2by Averina, Maria, Stylidis, Michael, Brox, Jan, Schirmer, Henrik“... T) in healthy subjects and assess cardiac biomarkers as screening tools for subclinical heart failure (HF) in a...”
Published in ESC Heart Failure (2022)
Get access
Get access
Get access
Article in Journal/Newspaper -
3by Averina, Maria, Stylidis, Michael, Brox, Jan, Schirmer, Henrik“... T) in healthy subjects and assess cardiac biomarkers as screening tools for subclinical heart failure (HF) in a...”
Published in ESC Heart Failure (2022)
Get access
Get access
Article in Journal/Newspaper -
4by Averina, Maria, Stylidis, Michael, Brox, Jan, Schirmer, Henrik“... T) in healthy subjects and assess cardiac biomarkers as screening tools for subclinical heart failure (HF) in a...”
Published in ESC Heart Failure (2022)
Get access
Get access
Get access
Article in Journal/Newspaper -
5by Ørbo, Marte Christine, Karlsen, Sidsel Fredheim, Pedersen, Ellinor Phillips, Hermansen, Stig Eggen, Rønning, Per Bjørnerud, Nergaard, Kathrine Aas, Næsheim, Torvind, Myrmel, Truls“... 49 years, 65% males). Acute cardiac failure was the dominant indication (58%), and venoarterial ECMO...”
Published in ESC Heart Failure (2019)
Get access
Get access
Get access
Article in Journal/Newspaper -
6by Marte Christine Ørbo, Sidsel Fredheim Karlsen, Ellinor Phillips Pedersen, Stig Eggen Hermansen, Per Bjørnerud Rønning, Kathrine Aas Nergaard, Torvind Næsheim, Truls Myrmel“... 49 years, 65% males). Acute cardiac failure was the dominant indication (58%), and venoarterial ECMO...”
Published in ESC Heart Failure (2019)
Get access
Get access
Article in Journal/Newspaper -
7by Ørbo, Marte, Karlsen, Sidsel Fredheim, Pedersen, Ellinor Phillips, Hermansen, Stig Eggen, Rønning, Per Bjørnerud, Aas, Kathrine Nergård, Næsheim, Torvind, Myrmel, Truls“... identified 74 ECMO-treated patients (mean age 49 years, 65% males). Acute cardiac failure was the dominant...”
Published in ESC Heart Failure (2019)
Get access
Get access
Article in Journal/Newspaper